COVID-19 vaccine: WHO in talks with Russia on its second vaccine EpiVacCorona
- Russia registered its second coronavirus vaccine on 14 October
- Developed by Vector State Research Center of Virology and Biotechnology, the EpiVacCorona vaccine completed its early stage human trials last month